ArticleInternational journal of cancer2014

Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma.

Subrata K Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.